0000899243-21-000453.txt : 20210105 0000899243-21-000453.hdr.sgml : 20210105 20210105181438 ACCESSION NUMBER: 0000899243-21-000453 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210104 FILED AS OF DATE: 20210105 DATE AS OF CHANGE: 20210105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Malik Rajesh CENTRAL INDEX KEY: 0001706853 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38096 FILM NUMBER: 21507770 MAIL ADDRESS: STREET 1: 79 TW ALEXANDER DRIVE STREET 2: 4501 RESEARCH COMMONS, SUITE 100 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: G1 Therapeutics, Inc. CENTRAL INDEX KEY: 0001560241 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263648180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 PARK OFFICES DRIVE STREET 2: SUITE 200 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-213-9835 MAIL ADDRESS: STREET 1: 700 PARK OFFICES DRIVE STREET 2: SUITE 200 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: G-Zero Therapeutics, Inc. DATE OF NAME CHANGE: 20121012 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-04 0 0001560241 G1 Therapeutics, Inc. GTHX 0001706853 Malik Rajesh C/O G1 THERAPEUTICS 700 PARK OFFICES DR, SUITE 200 RESEARCH TRIANGLE PARK NC 27709 0 1 0 0 Chief Medical Officer Common Stock 2021-01-04 4 A 0 11000 0.00 A 40200 D Stock Options (Right to Buy) 18.07 2021-01-04 4 A 0 58000 0.00 A 2031-01-04 Common Stock 58000 58000 D Represents a restricted stock unit ("RSU") award that vests 25% on January 4, 2022 and 12.5% semi-annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer common stock. Represents 29,200 shares of common stock and 11,000 restricted stock units The shares underlying this option vest as to 25% of the shares on January 4, 2022, with the remainder vesting in 36 equal installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date. /s/ James Stillman Hanson, attorney-in-fact 2021-01-05